Showing 1941-1950 of 3494 results for "".
The Impact of Clascoterone Topical Cream, 1%
https://practicaldermatology.com/issues/april-2025/the-impact-of-clascoterone-topical-cream-1/35605/Clascoterone topical cream, 1% (Winlevi, Sun Pharmaceuticals, Inc.) approved by the US Food and Drug Administration (FDA) in 2020 as the first novel drug introduced for the treatment of acne vulgaris since 1982, is indicated in the US for patients 12 years of age and older.DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-diagnosing-melanoma-using-deep-learning-model-new-adbry-approval/26445/In this week's DermWireTV, researchers develop a novel deep-learning model designed to more accurately diagnose melanoma; LEO Pharma receives a new approval for atopic dermatitis drug Adbry; and in our PA Perspectives segment, Andrew Mastro discusses how to build an inflammatory clinic.Galderma's Differin Goes OTC, CoolSculpting Approved for Upper Arms, ZO Skin Acquires ReFissa
https://practicaldermatology.com/videos/dermwire-tv/galderma-s-differin-goes-otc-coolsculpting-approved-for-upper-arms-zo-skin-acquires-refissa/18549/Galderma's Differin Gel formulation of adapalene 0.1% is now available over the counter at major retail and drug stores in the US. ZELTIQ® Aesthetics' CoolSculpting is now FDA-cleared for fat reduction in the upper arms. ZO Skin Health has acquired the worldwide rights to ReFissa from Suneva MedicalGalderma, Allergan Rosacea News, Dupilumab Data
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-galderma-allergan-rosacea-news-dupilumab-data/18591/Galderma Laboratories launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33. The FDA has accepted Allergan's New Drug Application (NDA) filing for oxymetazoline cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema assoSunscreen Water Seems All Washed Up; Fake Cosmeceuticals Raise Concerns
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-sunscreen-water-seems-all-washed-up-fake-cosmeceuticals-raise-concerns/19119/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine we take a look at drinkable sunscreen and school bans on sunscreens, get an update on Vegas Cosmetic Surgery, and meet the new face of AMBI skincare. Plus, our DermFocus investigates the problem of counterfeit cosThe Effect of the Microbiome
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/the-effect-of-the-microbiome/48776/Zoe Diana Draelos, MD, discusses the evolving role of skin microbiome dysbiosis, particularly Staphylococcus aureus, in perpetuating inflammation in atopic dermatitis.How Reviews Impact Your Practice Today and Tomorrow
https://practicaldermatology.com/topics/practice-management/how-reviews-impact-your-practice-today-and-tomorrow/19892/Are you harnessing the power of patient reviews? It has never been more important to generate quality reviews from real people. In this video, Ekwa Marketing explores the factors that drive positive reviews. And the opportunities presented by this platform to grow loyalty and attract new patients.The Safety of New Systemics
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/the-safety-of-new-systemics/33159/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, provides an overview of the safey of systemic therapies such as JAK inhibitors and other similar drugs, giving dermatologists a high-level look at what they need to help clinical decision-making.Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 1
https://practicaldermatology.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-1/54619/In the first installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, discuss the rationale behind studying adjuvant skincare and the often-overlooked role of barrier repair in psoriasis management.1 Draelos Z, HougeiHow do barrier dysfunction proteins interact with immune dysregulation to sustain AD?
https://practicaldermatology.com/videos/dermatology-hub-neuroimmune-network/how-do-barrier-dysfunction-proteins-interact-with-immune-dysregulation-to-sustain-ad/56736/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses whether barrier dysfunction drives inflammation and immune dysregulation, or vice versa, or both, in atopic dermatitis.